IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Clinical trial NCT05551507 · RECRUITING

Trial details

NCT number: NCT05551507
Sponsor: InxMed (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer

Start date: 2020-07-27
Primary completion: 2026-05-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.